Australis Capital Delays Filing of Executive Compensation Disclosure
Australis Capital Inc. (CSE: AUSA, OTC: AUSAF) announced a delay in filing its executive compensation disclosure, relying on exemptions under BC Instrument 51-516. The company plans to include this disclosure in the information circular for its upcoming Annual General Meeting. AUSA focuses on investments in the cannabis industry, with assets like Cocoon Technology, a cloud-based point-of-sale solution, and investments in Body and Mind Inc., Quality Green, and Folium Biosciences.
- AUSA plans to include executive compensation disclosure in the Annual General Meeting information circular, ensuring shareholder transparency.
- The company has a diversified portfolio in the cannabis industry, indicating potential for growth.
- Delay in executive compensation disclosure may raise concerns about governance and transparency.
- -
LAS VEGAS, Sept. 25, 2020 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") announces that it will be relying on the exemption provided in BC Instrument 51-516 — Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials (and similar exemptions provided by other relevant Canadian securities regulators) to delay the filing of its executive compensation disclosure. AUSA expects to include its executive compensation disclosure in the Annual General Meeting information circular to be sent to shareholders and filed on SEDAR later this year.
About Australis Capital Inc.
AUSA invests in, operates and builds differentiated companies primarily in the cannabis industry. AUSA focuses on significant near and mid-term opportunities with strong return potentials. AUSA's assets include Cocoon Technology, a cloud-based, self-service point of sale kiosk designed for cannabis dispensaries and other highly-regulated industries. The purpose-built platform features data analytics, privacy, security and regulatory compliance to drive enhanced consumer experience and generate incremental revenue for dispensary owners. AUSA's assets also include Body and Mind Inc., Quality Green, and Folium Biosciences.
The Company's Common shares trade on the CSE under the symbol "AUSA" and on the OTCQB under the symbol "AUSAF".
For further information about AUSA, please visit the website at ausa-corp.com or contact the Company by e-mail at ir@ausa-corp.com.
ON BEHALF OF THE BOARD OF DIRECTORS
"Cleve Tzung"
________________________________
Cleve Tzung
Chief Executive Officer
Forward-Looking Information Statement
This news release contains statements and information that, to the extent that they are not historical fact, constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information is based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all of such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking information to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.
The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accept responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:http://www.prnewswire.com/news-releases/australis-capital-delays-filing-of-executive-compensation-disclosure-301138327.html
SOURCE Australis Capital Inc.
FAQ
Why did Australis Capital delay the filing of its executive compensation disclosure?
What are the key assets of Australis Capital?
When will the executive compensation disclosure be filed?
What stock symbols does Australis Capital operate under?
